These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 20103650

  • 41. Pathways mediating VEGF-independent tumor angiogenesis.
    Ferrara N.
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):21-6. PubMed ID: 20005148
    [Abstract] [Full Text] [Related]

  • 42. VEGF and VEGFRs expression in oral squamous cell carcinoma.
    Mărgăritescu C, Pirici D, Simionescu C, Mogoantă L, Raica M, Stîngă A, Ciurea R, Stepan A, Stîngă A, Ribatti D.
    Rom J Morphol Embryol; 2009 Feb; 50(4):527-48. PubMed ID: 19942948
    [Abstract] [Full Text] [Related]

  • 43. Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
    Ferrara N.
    Curr Opin Hematol; 2010 May; 17(3):219-24. PubMed ID: 20308892
    [Abstract] [Full Text] [Related]

  • 44. Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review).
    Song G, Li Y, Jiang G.
    Oncol Rep; 2012 Dec; 28(6):1935-44. PubMed ID: 22993103
    [Abstract] [Full Text] [Related]

  • 45. Role of angiogenesis in the pathogenesis of cancer.
    Hoff PM, Machado KK.
    Cancer Treat Rev; 2012 Nov; 38(7):825-33. PubMed ID: 22677191
    [Abstract] [Full Text] [Related]

  • 46. VEGF as a target of therapy in gastrointestinal oncology.
    Los M, Voest EE, Borel Rinkes IH.
    Dig Surg; 2005 Nov; 22(4):282-93. PubMed ID: 16174985
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. III. Angiogenesis: complexity of tumor vasculature and microenvironment.
    Furuya M, Yonemitsu Y, Aoki I.
    Curr Pharm Des; 2009 Nov; 15(16):1854-67. PubMed ID: 19519428
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. An integrative model for vascular endothelial growth factor A as a tumour biomarker.
    Latham AM, Molina-París C, Homer-Vanniasinkam S, Ponnambalam S.
    Integr Biol (Camb); 2010 Sep; 2(9):397-407. PubMed ID: 20725676
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.
    Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S, Bergaya S, Benhamouda N, Tanchot C, Stockmann C, Combe P, Berger A, Zinzindohoue F, Yagita H, Tartour E, Taieb J, Terme M.
    J Exp Med; 2015 Feb 09; 212(2):139-48. PubMed ID: 25601652
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.